article thumbnail

Avalon Ventures Gets Exit At Sitari Pharmaceuticals

socalTECH

San Diego-based biotech investor Avalon Ventures has scored an exit, saying late Tuesday evening that it has entered into a definitive agreement with GlaxoSmithKline (GSK), to sell Sitari Pharmaceuticals to GSK. who also serves as President and CEO of COI and is a Managing Director at Avalon Ventures.

Avalon 100
article thumbnail

Avalon Ventures Backs Teambox

socalTECH

San Diego-based venture investor Avalon Ventures is the lead investor in a round for a developer of cloud-based, business collaboration software today. Avalon''s Rich Levandov was involved in the funding effort. teambox avalon ventures cloud software collaboration saas venture capital' READ MORE>>.

Avalon 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Avalon Ventures Gets Exit At Cloudant

socalTECH

San Diego-based venture investor Avalon Ventures has scored an exit this morning, after IBM said it has acquired Boston-based Cloudant , a developer of a NoSQL-based, cloud-based database. Financial terms of the buy were not disclosed. in funding.

Avalon 173
article thumbnail

Avalon Ventures Leads Round In AeroFS

socalTECH

San Diego-based venture investor Avalon Ventures is the lead investor in a new, $10M funding round for AeroFS , a developer of private cloud collaboration software. Avalon's Rich Levandov represents Avalon Ventures on the AeroFS board. AeroFS said the Series B funding also included NHN Investment. READ MORE>>.

Avalon 100
article thumbnail

Avalon Ventures Backs LoopIt

socalTECH

San Diego-based venture investment fund Avalon Ventures has made a seed investment in a developer of a social shopping service, LoopIt , according to the companies. Avalon's Rich Levandov was involved in the investment. Avalon's Rich Levandov was involved in the investment. Size of the funding was not announced.

Avalon 159
article thumbnail

Agenda and Speakers Announced for Xcelerating Life Sciences San Diego

Xconomy

Agenda topics include Successful Research & Development Models, What It Takes for Commercialization, and Building a Biotech Ecosystem in San Diego. Speakers include Jay Lichter, CEO of COI Pharma and Managing Director at Avalon Ventures; Ciara Kennedy, CEO of Amplyx; and Kim Kamdar, Partner at Domain Associates. $99

article thumbnail

Avalon Ventures Launches Trio Of Life Science Startups

socalTECH

San Diego-based Avalon Ventures said this morning that it has launched and funded three, new companies as part of its deal with GSK. Avalon Venturs said that Adrenergics , CadheRx Therapeutics , and Calporta Therapeutics have all received $10M in Series A funding, and will receive R&D support from Avalon Ventures and GSK.

Avalon 100